{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:33:11Z","timestamp":1773847991956,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10549-014-2886-x","type":"journal-article","created":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T00:48:37Z","timestamp":1393462117000},"page":"427-435","source":"Crossref","is-referenced-by-count":35,"title":["Digoxin use and risk of invasive breast cancer: evidence from the Nurses\u2019 Health Study and meta-analysis"],"prefix":"10.1007","volume":"144","author":[{"given":"Thomas P.","family":"Ahern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard A.","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"key":"2886_CR1","first-page":"1264","volume-title":"Harrison\u2019s principles of internal medicine","author":"T Harrison","year":"1998","unstructured":"Harrison T, Fauci A (1998) Harrison\u2019s principles of internal medicine. McGraw-Hill, New York, pp 1264\u20131295"},{"issue":"8115","key":"2886_CR2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(79)90996-6","volume":"1","author":"B Stenkvist","year":"1979","unstructured":"Stenkvist B, Bengtsson E, Eriksson O et al (1979) Cardiac glycosides and breast cancer. Lancet 1(8115):563","journal-title":"Lancet"},{"issue":"3","key":"2886_CR3","first-page":"493","volume":"6","author":"B Stenkvist","year":"1999","unstructured":"Stenkvist B (1999) Is digitalis a therapy for breast carcinoma? Oncol Rep 6(3):493\u2013496","journal-title":"Oncol Rep"},{"issue":"8135","key":"2886_CR4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0140-6736(79)91475-2","volume":"314","author":"D Cove","year":"1979","unstructured":"Cove D (1979) Digoxin and hormone receptors. Lancet 314(8135):204","journal-title":"Lancet"},{"issue":"2","key":"2886_CR5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jcem-46-2-338","volume":"46","author":"S Rifka","year":"1978","unstructured":"Rifka S, Pita J, Vigersky R et al (1978) Interaction of digitalis and spironolactone with human sex steroid receptors. J Clin Endocrinol Metab 46(2):338\u2013344","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2886_CR6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nrd2682","volume":"7","author":"I Prassas","year":"2008","unstructured":"Prassas I, Diamandis E (2008) Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov 7(11):926\u2013935","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2886_CR7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/mi.8.1.8","volume":"8","author":"R Newman","year":"2008","unstructured":"Newman R, Yang P, Pawlus A et al (2008) Cardiac glycosides as novel cancer therapeutic agents. Mol Interv 8(1):36\u201349","journal-title":"Mol Interv"},{"key":"2886_CR8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1749-6632.2003.tb07233.x","volume":"986","author":"O Aizman","year":"2003","unstructured":"Aizman O, Aperia A (2003) Na, K-ATPase as a signal transducer. Ann N Y Acad Sci 986:489\u2013496","journal-title":"Ann N Y Acad Sci"},{"issue":"23","key":"2886_CR9","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.lfs.2007.03.013","volume":"80","author":"M Nesher","year":"2007","unstructured":"Nesher M, Shpolansky U, Rosen H et al (2007) The digitalis-like steroid hormones: new mechanisms of action and biological significance. Life Sci 80(23):2093\u20132107","journal-title":"Life Sci"},{"issue":"6","key":"2886_CR10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2174\/092986711794927685","volume":"18","author":"C Riganti","year":"2011","unstructured":"Riganti C, Campia I, Kopecka J et al (2011) Pleiotropic effects of cardioactive glycosides. Curr Med Chem 18(6):872\u2013885","journal-title":"Curr Med Chem"},{"issue":"1","key":"2886_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-005-9053-3","volume":"96","author":"J-Q Chen","year":"2005","unstructured":"Chen J-Q, Contreras R, Wang R et al (2005) Sodium\/potasium ATPase (Na+, K+-ATPase) and ouabain\/related cardiac glycosides: a new paradigm for development of anti- breast cancer drugs? Breast Cancer Res Treat 96(1):1\u201315","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2886_CR12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1124\/mol.104.007302","volume":"67","author":"P Kometiani","year":"2005","unstructured":"Kometiani P, Liu L, Askari A (2005) Digitalis-induced signaling by Na+\/K+-ATPase in human breast cancer cells. Mol Pharmacol 67(3):929\u2013936","journal-title":"Mol Pharmacol"},{"issue":"2","key":"2886_CR13","first-page":"109","volume":"63","author":"K Winnicka","year":"2006","unstructured":"Winnicka K, Bielawski K, Bielawska A (2006) Cardiac glycosides in cancer research and cancer therapy. Acta Pol Pharm 63(2):109\u2013115","journal-title":"Acta Pol Pharm"},{"issue":"5","key":"2886_CR14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000238221","volume":"29","author":"I Falconer","year":"1983","unstructured":"Falconer I, Beresford A, Jones A et al (1983) Effect of digoxin on DNA synthesis and cell viability in human breast tumour tissue in organ culture. Chemotherapy 29(5):368\u2013372","journal-title":"Chemotherapy"},{"issue":"50","key":"2886_CR15","doi-asserted-by":"crossref","first-page":"19579","DOI":"10.1073\/pnas.0809763105","volume":"105","author":"H Zhang","year":"2008","unstructured":"Zhang H, Qian D, Tan Y et al (2008) Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci 105(50):19579\u201319586","journal-title":"Proc Natl Acad Sci"},{"issue":"16","key":"2886_CR16","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.1158\/0008-5472.CAN-09-0891","volume":"69","author":"Z Wang","year":"2009","unstructured":"Wang Z, Zheng M, Li Z et al (2009) Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition. Cancer Res 69(16):6556\u20136564","journal-title":"Cancer Res"},{"issue":"8407","key":"2886_CR17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(84)90915-2","volume":"2","author":"G Friedman","year":"1984","unstructured":"Friedman G (1984) Digitalis and breast cancer. Lancet 2(8407):875","journal-title":"Lancet"},{"issue":"1","key":"2886_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2407-1-11","volume":"1","author":"J Haux","year":"2001","unstructured":"Haux J, Klepp O, Spigset O et al (2001) Digitoxin medication and cancer; case control and internal dose-response studies. BMC Cancer 1(1):11","journal-title":"BMC Cancer"},{"issue":"1","key":"2886_CR19","first-page":"49","volume":"2","author":"B Stenkvist","year":"1980","unstructured":"Stenkvist B, Bengtsson E, Eklund G et al (1980) Evidence of a modifying influence of heart glucosides on the development of breast cancer. Anal Quant Cytol 2(1):49\u201354","journal-title":"Anal Quant Cytol"},{"issue":"6","key":"2886_CR20","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/bcr2205","volume":"10","author":"T Ahern","year":"2008","unstructured":"Ahern T, Lash T, S\u00f8rensen H et al (2008) Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study. Breast Cancer Res 10(6):R102","journal-title":"Breast Cancer Res"},{"issue":"16","key":"2886_CR21","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1200\/JCO.2010.32.8146","volume":"29","author":"R Biggar","year":"2011","unstructured":"Biggar R, Wohlfahrt J, Oudin A et al (2011) Digoxin use and the risk of breast cancer in women. J Clin Oncol 29(16):2165\u20132170","journal-title":"J Clin Oncol"},{"issue":"3","key":"2886_CR22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jnci\/djm270","volume":"100","author":"L Collins","year":"2008","unstructured":"Collins L, Marotti J, Baer H et al (2008) Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst 100(3):218\u2013221","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2886_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/bcr1029","volume":"7","author":"J Russo","year":"2005","unstructured":"Russo J, Moral R, Balogh G et al (2005) The protective role of pregnancy in breast cancer. Breast Cancer Res 7(3):131\u2013142","journal-title":"Breast Cancer Res"},{"issue":"16","key":"2886_CR24","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.ejca.2008.07.041","volume":"44","author":"J Cuzick","year":"2008","unstructured":"Cuzick J (2008) Hormone replacement therapy and the risk of breast cancer. Eur J Cancer 44(16):2344\u20132349","journal-title":"Eur J Cancer"},{"issue":"11","key":"2886_CR25","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/aje\/kwp304","volume":"170","author":"N Cook","year":"2009","unstructured":"Cook N, Rosner B, Hankinson S et al (2009) Mammographic screening and risk factors for breast cancer. Am J Epidemiol 170(11):1422\u20131432","journal-title":"Am J Epidemiol"},{"issue":"20","key":"2886_CR26","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/jama.291.20.2433","volume":"291","author":"M Terry","year":"2004","unstructured":"Terry M, Gammon M, Zhang F et al (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. J Am Med Assoc 291(20):2433\u20132440","journal-title":"J Am Med Assoc"},{"key":"2886_CR27","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Warwick J, Pinney E et al (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case\u2013control study. J Natl Cancer Inst. doi: 10.1093\/jnci\/djr079","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"2886_CR28","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1158\/1055-9965.EPI-07-2828","volume":"17","author":"K Moysich","year":"2008","unstructured":"Moysich K, Beehler G, Zirpoli G et al (2008) Use of common medications and breast cancer risk. Cancer Epidemiol Biomark Prev 17(7):1564\u20131595","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"2886_CR29","first-page":"274","volume":"87","author":"M Tria Tirona","year":"2013","unstructured":"Tria Tirona M (2013) Breast cancer screening update. Am Fam Physician 87(4):274\u2013278","journal-title":"Am Fam Physician"},{"key":"2886_CR30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/978-0-387-78818-0_6","volume":"630","author":"A Hjartaker","year":"2008","unstructured":"Hjartaker A, Langseth H, Weiderpass E (2008) Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 630:72\u201393","journal-title":"Adv Exp Med Biol"},{"key":"2886_CR31","doi-asserted-by":"crossref","unstructured":"Zalesin K, Franklin B, Miller W et al (2008) Impact of obesity on cardiovascular disease. Endocrinol Metab Clin N Am 37(3):663\u201384, ix","DOI":"10.1016\/j.ecl.2008.06.004"},{"issue":"17","key":"2886_CR32","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.2011.1590","volume":"306","author":"W Chen","year":"2011","unstructured":"Chen W, Rosner B, Hankinson S et al (2011) Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. J Am Med Assoc 306(17):1884\u20131890","journal-title":"J Am Med Assoc"},{"issue":"2","key":"2886_CR33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/oxfordjournals.aje.a009981","volume":"150","author":"B Takkouche","year":"1999","unstructured":"Takkouche B, Cadarso-Suarez C, Spiegelman D (1999) Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol 150(2):206\u2013215","journal-title":"Am J Epidemiol"},{"issue":"3","key":"2886_CR34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"issue":"1","key":"2886_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00001648-199001000-00009","volume":"1","author":"K Sullivan","year":"1990","unstructured":"Sullivan K, Foster D (1990) Use of the confidence interval function. Epidemiology 1(1):39\u201342","journal-title":"Epidemiology"},{"issue":"5","key":"2886_CR36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/oxfordjournals.aje.a010240","volume":"151","author":"S Greenland","year":"2000","unstructured":"Greenland S, Schwartzbaum J, Finkle W (2000) Problems due to small samples and sparse data in conditional logistic regression analysis. Am J Epidemiol 151(5):531\u2013539","journal-title":"Am J Epidemiol"},{"issue":"8","key":"2886_CR37","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1158\/1078-0432.CCR-11-1389","volume":"18","author":"R Biggar","year":"2012","unstructured":"Biggar R (2012) Molecular pathways: digoxin use and estrogen-sensitive cancers\u2014risks and possible therapeutic implications. Clin Cancer Res 18(8):2133\u20132137","journal-title":"Clin Cancer Res"},{"issue":"9382","key":"2886_CR38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","volume":"362","author":"V Beral","year":"2003","unstructured":"Beral V (2003) Million Women Study C. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362(9382):419\u2013427","journal-title":"Lancet"},{"issue":"24","key":"2886_CR39","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","volume":"332","author":"G Colditz","year":"1995","unstructured":"Colditz G, Hankinson S, Hunter D et al (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332(24):1589\u20131593","journal-title":"N Engl J Med"},{"issue":"7","key":"2886_CR40","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1056\/NEJM199302183280708","volume":"328","author":"G Braunstein","year":"1993","unstructured":"Braunstein G (1993) Gynecomastia. N Engl J Med 328(7):490\u2013495","journal-title":"N Engl J Med"},{"issue":"8","key":"2886_CR41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJM195302192480802","volume":"248","author":"E Lewinn","year":"1953","unstructured":"Lewinn E (1953) Gynecomastia during digitalis therapy: report of eight additional cases with liver-function studies. N Engl J Med 248(8):316\u2013320","journal-title":"N Engl J Med"},{"issue":"4","key":"2886_CR42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/028418601750288181","volume":"40","author":"M Ewertz","year":"2001","unstructured":"Ewertz M, Holmberg L, Tretli S et al (2001) Risk factors for male breast cancer\u2014a case\u2013control study from Scandinavia. Acta Oncol 40(4):467\u2013471","journal-title":"Acta Oncol"},{"issue":"4","key":"2886_CR43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ijc.2910450415","volume":"45","author":"M Lenfant-Pejovic","year":"1990","unstructured":"Lenfant-Pejovic M, Mlika-Cabanne N, Bouchardy C et al (1990) Risk factors for male breast cancer: a Franco\u2013Swiss case\u2013control study. Int J Cancer 45(4):661\u2013665","journal-title":"Int J Cancer"},{"issue":"1","key":"2886_CR44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/2159-8274.CD-10-0020","volume":"1","author":"E Platz","year":"2011","unstructured":"Platz E, Yegnasubramanian S, Liu J et al (2011) A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov 1(1):68\u201377","journal-title":"Cancer Discov"},{"issue":"2","key":"2886_CR45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3816\/CGC.2002.n.009","volume":"1","author":"W Oh","year":"2002","unstructured":"Oh W (2002) The evolving role of estrogen therapy in prostate cancer. Clin Prost Cancer 1(2):81\u201389","journal-title":"Clin Prost Cancer"},{"issue":"1","key":"2886_CR46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.20.14.1","volume":"14","author":"J Weiss","year":"2005","unstructured":"Weiss J, Moysich K, Swede H (2005) Epidemiology of male breast cancer. Cancer Epidemiol Biomark Prev 14(1):20\u201326","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"2886_CR47","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ijc.26424","volume":"131","author":"R Biggar","year":"2012","unstructured":"Biggar R, Wohlfahrt J, Melbye M (2012) Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix. Int J Cancer 131(3):716\u2013721","journal-title":"Int J Cancer"},{"issue":"22","key":"2886_CR48","doi-asserted-by":"crossref","first-page":"14921","DOI":"10.1074\/jbc.M808355200","volume":"284","author":"J Tian","year":"2009","unstructured":"Tian J, Li X, Liang M et al (2009) Changes in sodium pump expression dictate the effects of ouabain on cell growth. J Biol Chem 284(22):14921\u201314929","journal-title":"J Biol Chem"},{"issue":"1","key":"2886_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-005-9053-3","volume":"96","author":"J Chen","year":"2006","unstructured":"Chen J, Contreras R, Wang R et al (2006) Sodium\/potassium ATPase (Na+, K+-ATPase) and ouabain\/related cardiac glycosides: a new paradigm for development of anti-breast cancer drugs? Breast Cancer Res Treat 96(1):1\u201315","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2886_CR50","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/bcr3186","volume":"14","author":"R Ritte","year":"2012","unstructured":"Ritte R, Lukanova A, Berrino F et al (2012) Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res 14(3):R76","journal-title":"Breast Cancer Res"},{"issue":"12","key":"2886_CR51","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/oxfordjournals.aje.a117592","volume":"142","author":"S Greenland","year":"1995","unstructured":"Greenland S, Finkle W (1995) A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol 142(12):1255\u20131264","journal-title":"Am J Epidemiol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2886-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-2886-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2886-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T20:10:43Z","timestamp":1689019843000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-2886-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["2886"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-2886-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,28]]}}}